Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels

Clinica Chimica Acta

Volumn 413, Issue 21-23, 2012, Pages 1796-1799

  Du, Dongning ^a,b,c   Zhu, Xuejuan ^a   Kuno, Atsushi ^b   Matsuda, Atsushi ^b   Tsuruno, Chikayuki ^d   Yu, Demin ^a   Zhang, Yan ^c,e   Ikehara, Yuzuru ^b   Tanaka, Yasuhito ^f   Zhang, Xinxin ^a   Narimatsu, Hisashi ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c SCSB (China) AIST (Japan) Joint Medical Glycomics Laboratory   (China)

^d SYSMEX CORPORATION   (Japan)

^e Shanghai Jiao Tong University   (China)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Alanine aminotransferase; Cirrhosis; Glycomarker; Hepatitis B; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; OROSOMUCOID;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; HEPATITIS B; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY; TRIPLEX LECTIN ANTIBODY IMMUNOASSAY;

ADULT; ALANINE TRANSAMINASE; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LECTINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

HEPATITIS B VIRUS;

EID: 84864490721     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.07.005     Document Type: Article

References (28)

1. Lavanchy D., Hepatitis B. virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
2. Lu F.M., Zhuang H. Management of hepatitis B in China. Chin Med J-Peking 2009, 122:3-4.
3. Afdhal N., McHutchison J., Brown R., et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008, 48:1000-1007.
4. Alberti A., Clumeck N., Collins S., et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005, 42:615-624.
5. Hoofnagle J.H., Doo E., Liang T.J., Fleischer R., Lok A.S. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007, 45:1056-1075.
6. Colloredo G., Guido M., Sonzogni A., Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003, 39:239-244.
7. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. N Engl J Med 2001, 344:495-500.
8. Piccinino F., Sagnelli E., Pasquale G., Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986, 2:165-173.
9. Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009, 16:300-314.
10. Forns X., Ampurdanes S., Llovet J.M., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002, 36:986-992.
11. Patel K., Gordon S.C., Jacobson I., et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004, 41:935-942.
12. Rosenberg W.M., Voelker M., Thiel R., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004, 127:1704-1713.
13. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003, 29:1705-1713.
14. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
15. Friedrich-Rust M., Ong M.F., Martens S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974.
16. Shaheen A.A., Wan A.F., Myers R.P. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007, 102:2589-2600.
17. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075.
18. Turner G.A. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 1992, 208:149-171.
19. Kuno A., Ikehara Y., Tanaka Y., et al. LecT-Hepa: a triplex lectin-antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine. Clin Chim Acta 2011, 412:1767-1772.
20. Ito K., Kuno A., Ikehara Y., et al. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients. Hepatology 2012, 10.1002/hep.25815.
21. Leevy C.M. Diseases of the liver and biliary tract: standardization of nomenclature, diagnostic criteria, and prognosis 1994, Raven Press, New York.
22. Chang T.T., Liaw Y.F., Wu S.S., et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010, 52:886-893.
23. Wong V.W., Vergniol J., Wong G.L., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010, 51:454-462.
24. Ganne-Carrie N., Ziol M., de Ledinghen V., et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006, 44:1511-1517.
25. Bedossa P., Dargere D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
26. Colletta C., Smirne C., Fabris C., et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005, 42:838-845.
27. Sagir A., Erhardt A., Schmitt M., Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008, 47:592-595.
28. Arena U., Vizzutti F., Corti G., et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008, 47:380-384.